NCT05510180View on ClinicalTrials.gov

CVD Risk Profile in Children With HCM

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Hypertrophic Cardiomyopathy
Trial Locations (10)

T6G 2B7

Stollery Children's Hospital, Edmonton

V6H 3N1

BC Children's Hospital, Vancouver

R3A 1S1

Children's Hospital, Winnipeg

B3K 6R8

IWK Health Centre, Halifax

M5G 1X8

Hospital for Sick Children, Toronto

H3T 1C5

CHU Sainte-Justine, Montreal

H4A 3J1

Montreal Children's Hospital, Montreal

G1V 4G2

Centre Hospitalier de l'Université Laval, Québec

J1H 5N4

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

S7N 0W8

Jim Pattison Children's Hospital, Saskatoon

All Listed Sponsors
lead

University of Alberta

OTHER

NCT05510180 - CVD Risk Profile in Children With HCM | Biotech Hunter | Biotech Hunter